glp 1 agonist uses Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Comparing Ozempic, Wegovy and Other
Description
ADIS DRUG PROFILE , (2005)
Make sure you have access to claims-level rebate data, no spreads, and full visibility into how GLP-1s are covered, reimbursed, and dispensed
Semaglutide, Exenatide, and Tirzepatide now average between $330 and $430 per gram
Non-GLP-1 alternatives have completely different side effect profiles
Read here for more information on the class of drugs known as GLP-1 agonists
